Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Feb;76(2):862–866. doi: 10.1073/pnas.76.2.862

Identification of 7,12-dimethylbenz[a]anthracene metabolites that lead to mutagenesis in mammalian cells

Eliezer Huberman *, Ming W Chou †, Shen K Yang †
PMCID: PMC383073  PMID: 106395

Abstract

The mutagenicity of 7,12-dimethylbenz[a]-anthracene (DMBA) and 11 of its enzymatically derived metabolites was tested with Chinese hamster V79 cells for identification of mutagenic metabolites. The metabolites consisted of 7-hydroxymethyl-12-methylbenz[a]anthracene, 7-methyl-12-hydroxymethylbenz[a]anthracene, 7,12-dihydroxymethylbenz[a]anthracene, three trans-3,4-diols, two trans-5,6-diols, and three trans-8,9-diols, all of which derived from DMBA or from the hydroxymethyl derivatives. Mutations were characterized by resistance to ouabain and 6-thioguanine. None of the tested metabolites were mutagenic in V79 cells, which do not metabolize polycyclic aromatic hydrocarbons. Therefore, mutagenesis in the V79 cells was tested in the presence of golden hamster cells capable of metabolizing polycyclic aromatic hydrocarbons (cell-mediated assay). In this assay, DMBA, 7-hydroxymethyl-12-methylbenz[a]anthracene, 7-methyl-12-hydroxymethylbenz[a]anthracene, and their trans3,4-diols were mutagenic for both genetic markers, and the mutagenic response increased as a function of the hydrocarbon dose. All other metabolites were either inactive or showed up to a 4-fold higher mutation frequency than the untreated V79 cells for ouabain and 6-thioguanine resistance. The DMBA-trans-3,4-diol was the only metabolite that was more active than DMBA itself; at 0.05 μM it was 6-8 times more active than DMBA itself; at 0.05 μM it was 6-8 times more active than DMBA in inducing both ouabain and 6-thioguanine resistance. This diol was mutagenic at a dose as low as 0.01 μM. Mutagenesis by DMBA and the trans-3,4-diols was inhibited by 7,8-benzoflavone, an inhibitor of mixed-function oxidases. Analysis of DMBA metabolism in intact golden hamster cells indicated that DMBA-trans-3,4-diol is one of the major metabolites produced. Our results therefore suggest that DMBA-trans-3,4-diol may be metabolized to a diol-epoxide, presumably the trans-3,4-diol-1,2-epoxide, which may be a major reactive metabolite responsible for DMBA mutagenicity in mammalian cells.

Keywords: cell-mediated mutagenesis; 6-thioguanine and ouabain resistance; high-pressure liquid chromatography; metabolic formation of a trans-3,4-dihydrodiol

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ames B. N., Durston W. E., Yamasaki E., Lee F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2281–2285. doi: 10.1073/pnas.70.8.2281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barrett J. C., Ts'o P. O. Relationship between somatic mutation and neoplastic transformation. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3297–3301. doi: 10.1073/pnas.75.7.3297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett J. C., Tsutsui T., Ts'o P. O. Neoplastic transformation induced by a direct perturbation of DNA. Nature. 1978 Jul 20;274(5668):229–232. doi: 10.1038/274229a0. [DOI] [PubMed] [Google Scholar]
  4. Bigger C. A., Tomaszewski J. E., Dipple A. Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system. Biochem Biophys Res Commun. 1978 Jan 13;80(1):229–235. doi: 10.1016/0006-291x(78)91127-0. [DOI] [PubMed] [Google Scholar]
  5. Boyland E., Sims P., Huggins C. Induction of adrenal damage and cancer with metabolites of 7,12-dimethylbenz(a)anthracene. Nature. 1965 Aug 21;207(999):816–817. doi: 10.1038/207816b0. [DOI] [PubMed] [Google Scholar]
  6. Boyland E., Sims P. The effect of pretreatment with adrenal-protecting compounds on the metabolism of 7,12-dimethylbenz[a]anthracene and related compounds by rat-liver homogenates. Biochem J. 1967 Aug;104(2):394–403. doi: 10.1042/bj1040394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975 May 15;255(5505):197–200. doi: 10.1038/255197a0. [DOI] [PubMed] [Google Scholar]
  8. Chan G. L., Little J. B. Induction of ouabain-resistant mutations in C3H 10T1/2 mouse cells by ultraviolet light. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3363–3366. doi: 10.1073/pnas.75.7.3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chou M. W., Yang S. K. Identification of four trans-3,4-dihydrodiol metabolites of 7,12-dimethylbenz[a]anthracene and their in vitro DNA-binding activities upon further metabolism. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5466–5470. doi: 10.1073/pnas.75.11.5466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diamond L., Gelboin H. V. Alpha-naphthoflavone: an inhibitor of hydrocarbon cytotoxicity and microsomal hydroxylase. Science. 1969 Nov 21;166(3908):1023–1025. doi: 10.1126/science.166.3908.1023. [DOI] [PubMed] [Google Scholar]
  11. Dipple A., Nebzydoski J. A. Evidence for the involvement of a diol-epoxide in the binding of 7,12-dimethylbenz(a)anthracene to DNA in cells in culture. Chem Biol Interact. 1978 Jan;20(1):17–26. doi: 10.1016/0009-2797(78)90077-7. [DOI] [PubMed] [Google Scholar]
  12. Gelboin H. V., Wiebel F., Diamond L. Dimethylbenzanthracene tumorigenesis and aryl hydrocarbon hydroxylase in mouse skin: inhibition by 7,8-benzoflavone. Science. 1970 Oct 9;170(3954):169–171. doi: 10.1126/science.170.3954.169. [DOI] [PubMed] [Google Scholar]
  13. HUGGINS C., GRAND L. C., BRILLANTES F. P. Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature. 1961 Jan 21;189:204–207. doi: 10.1038/189204a0. [DOI] [PubMed] [Google Scholar]
  14. Harvey R. G., Dunne F. B. Multiple regions of metabolic activation of carcinogenic hydrocarbons. Nature. 1978 Jun 15;273(5663):566–568. doi: 10.1038/273566a0. [DOI] [PubMed] [Google Scholar]
  15. Heidelberger C. Chemical carcinogenesis. Annu Rev Biochem. 1975;44:79–121. doi: 10.1146/annurev.bi.44.070175.000455. [DOI] [PubMed] [Google Scholar]
  16. Huberman E., Fogel M. Activation of carcinogenic polycyclic hydrocarbons in polyoma-virus-transformed cells as a prerequisite for polyoma virus induction. Int J Cancer. 1975 Jan 15;15(1):91–98. doi: 10.1002/ijc.2910150111. [DOI] [PubMed] [Google Scholar]
  17. Huberman E., Kuroki T., Marquardt H., Selkirk J. K., Heidelberger C., Grover P. L., Sims P. Transformation of hamster embryo cells by epoxides and other derivatives of polycyclic hydrocarbons. Cancer Res. 1972 Jul;32(7):1391–1396. [PubMed] [Google Scholar]
  18. Huberman E., Mager R., Sachs L. Mutagenesis and transformation of normal cells by chemical carcinogens. Nature. 1976 Nov 25;264(5584):360–361. doi: 10.1038/264360a0. [DOI] [PubMed] [Google Scholar]
  19. Huberman E., Sachs L. Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer. 1974 Mar 15;13(3):326–333. doi: 10.1002/ijc.2910130308. [DOI] [PubMed] [Google Scholar]
  20. Huberman E., Sachs L. Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc Natl Acad Sci U S A. 1976 Jan;73(1):188–192. doi: 10.1073/pnas.73.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huberman E., Sachs L., Yang S. K., Gelboin V. Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci U S A. 1976 Feb;73(2):607–611. doi: 10.1073/pnas.73.2.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Huberman E., Selkirk J. K., Heidelberger C. Metabolism of polycyclic aromatic hydrocarbons in cell cultuires. Cancer Res. 1971 Dec;31(12):2161–2167. [PubMed] [Google Scholar]
  23. Huberman E., Yang S. K., McCourt D. W., Gelboin H. V. Mutagenicity to mammalian cells in culture by (+) and (-) trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrenes and the hydrolysis and reduction products of two stereoisomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. Cancer Lett. 1978 Jan;4(1):35–43. doi: 10.1016/s0304-3835(78)93247-0. [DOI] [PubMed] [Google Scholar]
  24. Ivanovic V., Geacintov N. E., Jeffrey A. M., Fu P. P., Harvey R. G., Weinstein I. B. Cell and microsome mediated binding of 7,12-dimethylbenz(a)anthracene to DNA studied by fluorescence spectroscopy. Cancer Lett. 1978 Mar;4(3):131–140. doi: 10.1016/s0304-3835(78)93962-9. [DOI] [PubMed] [Google Scholar]
  25. Ivanovic V., Geacintov N. E., Yamasaki H., Weinstein I. B. DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo[a]pyrene. Biochemistry. 1978 May 2;17(9):1597–1603. doi: 10.1021/bi00602a003. [DOI] [PubMed] [Google Scholar]
  26. King H. W., Osborne M. R., Beland F. A., Harvey R. G., Brookes P. (+/-)-7alpha,8beta-dihydroxy-9beta,10beta-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene is an intermediate in the metabolism and binding to DNA of benzo(a)pyrene. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2679–2681. doi: 10.1073/pnas.73.8.2679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Langenbach R., Freed H. J., Huberman E. Liver cell-mediated mutagenesis of mammalian cells by liver carcinogens. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2864–2867. doi: 10.1073/pnas.75.6.2864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Malaveille C., Bartsch H., Grover P. L., Sims P. Mutagenicity of non-K-region diols and diol-epoxides of benz(a)anthracene and benzo(a)pyrene in S. typhimurium TA 100. Biochem Biophys Res Commun. 1975 Sep 16;66(2):693–700. doi: 10.1016/0006-291x(75)90565-3. [DOI] [PubMed] [Google Scholar]
  29. Malaveille C., Tierney B., Grover P. L., Sims P., Bartsch H. High microsome-mediated mutagenicity of the 3,4-dihydrodiol of 7-methylbenz[a]anthracene in S. typhimurium TA 98. Biochem Biophys Res Commun. 1977 Mar 21;75(2):427–433. doi: 10.1016/0006-291x(77)91060-9. [DOI] [PubMed] [Google Scholar]
  30. Marquardt H., Grover P. L., Sims P. In vitro malignant transformation of mouse fibroblasts by non-K-region dihydrodiols derived from 7-methylbenz(a)anthracene, 7,12-dimethylbenz(a)anthracene, and benzo(a)pyrene. Cancer Res. 1976 Jun;36(6):2059–2064. [PubMed] [Google Scholar]
  31. McCann J., Choi E., Yamasaki E., Ames B. N. Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5135–5139. doi: 10.1073/pnas.72.12.5135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. Cancer Res. 1978 Jun;38(6):1479–1496. [PubMed] [Google Scholar]
  33. Moschel R. C., Baird W. M., Dipple A. Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA binding. Biochem Biophys Res Commun. 1977 Jun 20;76(4):1092–1098. doi: 10.1016/0006-291x(77)90968-8. [DOI] [PubMed] [Google Scholar]
  34. Newbold R. F., Brookes P. Exceptional mutagenicity of a benzo(a)pyrene diol epoxide in cultured mammalian cells. Nature. 1976 May 6;261(5555):52–54. doi: 10.1038/261052a0. [DOI] [PubMed] [Google Scholar]
  35. O'Neill J. P., Brimer P. A., Machanoff R., Hirsch G. P., Hsie A. W. A quantitative assay of mutation induction at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells (CHO/HGPRT system): development and definition of the system. Mutat Res. 1977 Oct;45(1):91–101. doi: 10.1016/0027-5107(77)90047-1. [DOI] [PubMed] [Google Scholar]
  36. Selkirk J. K. Benzo[a]pyrene carcinogenesis: a biochemical selection mechanism. J Toxicol Environ Health. 1977 Jul;2(6):1245–1258. doi: 10.1080/15287397709529527. [DOI] [PubMed] [Google Scholar]
  37. Selkirk J. K., Croy R. G., Gelboin H. V. Benzo(a)pyrene metabolites: efficient and rapid separation by high-pressure liquid chromatography. Science. 1974 Apr 12;184(4133):169–171. doi: 10.1126/science.184.4133.169. [DOI] [PubMed] [Google Scholar]
  38. Sims P., Grover P. L. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res. 1974;20:165–274. doi: 10.1016/s0065-230x(08)60111-6. [DOI] [PubMed] [Google Scholar]
  39. Sims P., Grover P. L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature. 1974 Nov 22;252(5481):326–328. doi: 10.1038/252326a0. [DOI] [PubMed] [Google Scholar]
  40. Slaga T. J., Bowden G. T., Scribner J. D., Boutwell R. K. Dose-response studies on the ability of 7,12-dimethylbenz(alpha)anthracene and benz(alpha)anthracene to initiate skin tumors. J Natl Cancer Inst. 1974 Nov;53(5):1337–1340. doi: 10.1093/jnci/53.5.1337. [DOI] [PubMed] [Google Scholar]
  41. Slaga T. J., Huberman E., Selkirk J. K., Harvey R. G., Bracken W. M. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides. Cancer Res. 1978 Jun;38(6):1699–1704. [PubMed] [Google Scholar]
  42. Thakker D. R., Levin W., Wood A. W., Conney A. H., Stoming T. A., Jerina D. M. Metabolic formation of 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene: a potential proximate carcinogen from 3-methylcholanthrene. J Am Chem Soc. 1978 Jan 18;100(2):645–647. doi: 10.1021/ja00470a057. [DOI] [PubMed] [Google Scholar]
  43. Thakker D. R., Yagi H., Lu A. Y., Levin W., Conney A. H. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3381–3385. doi: 10.1073/pnas.73.10.3381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vigny P., Duquesne M., Coulomb H., Tierney B., Grover P. L., Sims P. Fluorescence spectral studies on the metabolic activation of 3-methylcholanthrene and 7,12-dimethylbenz[a]anthracene in mouse skin. FEBS Lett. 1977 Oct 15;82(2):278–282. doi: 10.1016/0014-5793(77)80602-9. [DOI] [PubMed] [Google Scholar]
  45. Walters M. A. The induction of lung tumours by the injection of 9,10-dimethyl-1,2-benzanthracene (DMBA) into newborn suckling and young adult mice. A dose response study. Br J Cancer. 1966 Mar;20(1):148–160. doi: 10.1038/bjc.1966.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Weinstein I. B., Jeffrey A. M., Jennette K. W., Blobstein S. H., Harvey R. G., Harris C., Autrup H., Kasai H., Nakanishi K. Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science. 1976 Aug 13;193(4253):592–595. doi: 10.1126/science.959820. [DOI] [PubMed] [Google Scholar]
  47. Wood A. W., Levin W., Lu A. Y., Ryan D., West S. B., Lehr R. E., Schaefer-Ridder M., Jerina D. M., Conney A. H. Mutagenicity of metabolically activated benzo[a]anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic hydrocarbons. Biochem Biophys Res Commun. 1976 Sep 20;72(2):680–686. doi: 10.1016/s0006-291x(76)80093-9. [DOI] [PubMed] [Google Scholar]
  48. Wood A. W., Levin W., Ryan D., Thomas P. E., Yagi H., Mah H. D., Thakker D. R., Jerina D. M., Conney A. H. High mutageniticity of metabolically activated chrysene 1,2 dihydrodiol: evidence for bay region activation of chrysene. Biochem Biophys Res Commun. 1977 Oct 10;78(3):847–854. doi: 10.1016/0006-291x(77)90500-9. [DOI] [PubMed] [Google Scholar]
  49. Wood A. W., Levin W., Thomas P. E., Ryan D., Karle J. M., Yagi H., Jerina D. M., Conney A. H. Metabolic activation of dibenzo(a,h)anthracene and its dihydrodiols to bacterial mutagens. Cancer Res. 1978 Jul;38(7):1967–1973. [PubMed] [Google Scholar]
  50. Wood A. W., Wislocki P. G., Chang R. L., Levin W., Lu A. Y., Yagi J., Hernandez O., Herina D. M., Conney A. H. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res. 1976 Sep;36(9 PT1):3358–3366. [PubMed] [Google Scholar]
  51. Yang S. K., Dower W. V. Metabolic pathways of 7,12-dimethylbenz[a]anthracene in hepatic microsomes. Proc Natl Acad Sci U S A. 1975 Jul;72(7):2601–2605. doi: 10.1073/pnas.72.7.2601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yang S. K., McCourt D. W., Gelboin H. V. The mechanism of hydrolysis of the non-K-region benzo[a]pyrene diol epoxide r-7, t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene. J Am Chem Soc. 1977 Jul 20;99(15):5130–5134. doi: 10.1021/ja00457a037. [DOI] [PubMed] [Google Scholar]
  53. Yang S. K., McCourt D. W., Roller P. P., Gelboin H. V. Enzymatic conversion of benzo(a)pyrene leading predominantly to the diol-epoxide r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene through a single enantiomer of r-7, t-8-dihydroxy-7,8-dihydrobenzo(a)pyrene. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2594–2598. doi: 10.1073/pnas.73.8.2594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. van Zeeland A. A., Simons J. W. The effect of calf serum on the toxicity of 8-azaguanine. Mutat Res. 1975 Jan;27(1):135–138. doi: 10.1016/0027-5107(75)90283-3. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES